Background: Upper-limb lymphedema (ULL) occurs in 15-20% of women after breast-cancer treatment. Its intensive therapy relies on complete (complex) decongestive physiotherapy (CDP), whose duration is not well-established.
Objective: Determine optimal intensive-phase CDP duration for lymphedema-volume reduction and factors predicting its success, with the hope of halving it from 11 to 4 days.
Methods: All patients with ULL (08/2011-06/2012) after breast-cancer treatment referred to our Department of Lymphology in a rehabilitation facility for 11 days of CDP were eligible. Lymphedema volume was calculated using the truncated-cone formula. Volume reduction considered clinically relevant after 4 days was defined as ≥ 75% of the total reduction obtained after 11 days.
Results: We included 129 women (median age: 64 (range: 42-88) years). Mean (sd) lymphedema volume was 907 (558) ml at CDP onset, decreased to 712 (428) ml after 4 days (vs. onset, P<.0001) and 606 (341) ml after 11 days (vs. 4, P<.0001), corresponding to 33% total lymphedema-volume reduction. For all patients, 4 days of CDP achieved 63% (sd 40%) of that total reduction, with ≥ 75% for 50 (39%) patients. Surgery-to-lymphedema-onset interval >2 years was the only factor significantly associated with 4 days achieving ≥ 75% of the total lymphedema-volume reduction.
Conclusion: Intensive phase CDP for 11 days obtained significantly more volume reduction of breast cancer-related ULL than 4.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ygyno.2013.07.101 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Demonstration of the effectiveness of complete decongestive treatment in secondary lymphedema developing after total knee arthroplasty.
Eur J Orthop Surg Traumatol
December 2024
Istanbul Physical Medicine and Rehabilitation Training Research Hospital, Istanbul, Turkey.
Objective: The aim of the current study is to demonstrate the treatment results of patients with lymphedema that developed after total knee arthroplasty (TKA) and to compare these results with those of patients with secondary lymphedema non-TKA.
Methods: A total of 63 patients diagnosed with secondary lymphedema and who received complete decongestive treatment (MLD + bandaging + exercise) at the lymphedema treatment unit of Istanbul Physical Medicine and Rehabilitation Training Research Hospital between June 1, 2023, and February 1, 2024, were included in our retrospective study. The circumference of both metatarsophalangeal joints was measured, and leg diameter measurements were made from the lateral malleolus to the proximal 10th, 20th, and 30th centimeters.
Complex Decongestive Therapy Improves Gait Speed in Patients with Lower Limb Lymphedema.
Lymphat Res Biol
December 2024
Department of Physical Medicine and Rehabilitation, Ankara City Hospital, Ankara, Turkey.
Secondary lymphedema is acquired and caused by obstruction or injury to a normally developed lymphatic system. Loss of mobility is a common problem in patients with secondary lower limb lymphedema (LLL) following cancer treatment. In this study, we examined the effect of complex decongestive therapy (CDT) on motor function and mobility in patients with LLL.
View Article and Find Full Text PDFEffects of complex decongestive physical therapy on upper limb circumference and sensory function in post-mastectomy lymph oedema, A quasi-experimental study.
J Pak Med Assoc
December 2024
Riphah International University, Lahore, Pakistan.
The quasi-experimental study was conducted at the Allied Hospital, Faisalabad to investigate the effect of complex decongestive physical therapy on sensory testing in postmastectomy- related lymphoedema patients. The sample comprised 18 participants enrolled using convenience sampling technique. All the participants received complex decongestive physical therapy during 5 sessions per week for 3 weeks.
View Article and Find Full Text PDFSafety Evaluation of a Device for Treatment of Lymphedema of the Upper Extremity.
Lymphat Res Biol
December 2024
Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA.
Lymphedema is a chronic condition characterized by dysfunction of the lymphatic system. There is currently no available cure. The standard of care is complete decongestive physiotherapy performed by a lymphedema therapist.
View Article and Find Full Text PDFEfficacy of complex decongestive therapy on venous flow, internal saphenous diameter, edema, fat mass of the limbs and quality of life in patients with chronic venous insufficiency: A randomized clinical trial.
J Vasc Surg Venous Lymphat Disord
November 2024
i+HeALTH, Department of Health Sciences, Miguel de Cervantes European University, Valladolid, Spain.
Objective: Demonstrate the effectiveness of complex decongestive therapy (CDT) in patients with chronic venous insufficiency (CVI).
Methods: A single-blind randomized controlled trial was conducted, where the participants were patients with CVI (n = 21/42) were assigned randomly to an experimental group (n = 11/22) or a control group (n = 9/18). A treatment of CDT (manual lymphatic drainage, intermittent pneumatic presotherapy, bilayer bandage) was applied to the experimental group for 4 weeks 2 days per week and no treatment was applied to the control group.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!